|
|
Volumn 10, Issue 3, 2014, Pages 127-
|
|
Rheumatoid arthritis: Are FcRL4+ B cells the next target for RA biologic therapy?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
CYTOKINE;
FC RECEPTOR;
FCRL4 PROTEIN, HUMAN;
ARTICLE;
B LYMPHOCYTE;
BIOLOGICAL THERAPY;
DRUG EFFECT;
HUMAN;
METABOLISM;
PATHOLOGY;
RHEUMATOID ARTHRITIS;
SYNOVIUM;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
B-LYMPHOCYTES;
BIOLOGICAL THERAPY;
CYTOKINES;
HUMANS;
RECEPTORS, FC;
SYNOVIAL MEMBRANE;
|
|
EID: 85027929924
PISSN: None
EISSN: 17594804
Source Type: Journal
DOI: 10.1038/nrrheum.2014.8 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
